Toddlers with a peanut allergy built tolerance with 3 years of epicutaneous immunotherapy after a year of placebo use, ...

Our brain's reward system processes and reinforces pleasurable experiences, motivating us to seek out and engage in rewarding ...

With a little planning, people can enjoy the celebrations without spending them sniffing, itchy or reaching for tissues.

Learn how allergen immunotherapy offers long-term control in local allergic rhinitis and prevents asthma and new ...

Small airway dysfunction is common in adult well-controlled asthma and is independently linked to increased risk for future exacerbations.

The risk for new-onset respiratory conditions was significantly raised among veterans deployed to Iraq and Afghanistan, ...

How would you describe asthma? Is it “a common condition that affects your breathing”, as the UK's National Health Service describes it? Is it “a long-term lung condition”, like the charity Asthma + ...

This Comment is an urgent global call to action. I, as a pulmonologist, have concerns regarding the impacts of environmental ...

Remibrutinib showed rapid and sustained efficacy in CSU, with significant symptom reduction by week 2, maintained over 52 weeks. The pooled analysis of REMIX-1 and REMIX-2 trials highlighted ...

Patients with chronic spontaneous urticaria (CSU) treated with remibrutinib (Rhapsido; Novartis) in the REMIX-1 ( NCT05030311 ...